Vis enkel innførsel

dc.contributor.authorLukic, Marko
dc.contributor.authorNilsson, Lena Maria
dc.contributor.authorSkeie, Guri
dc.contributor.authorLindahl, Bernt
dc.contributor.authorBraaten, Tonje
dc.date.accessioned2019-02-06T14:06:20Z
dc.date.available2019-02-06T14:06:20Z
dc.date.issued2018-02-23
dc.description.abstractStudies on the association between heavy coffee consumption and risk of less frequently diagnosed cancers are scarce. We aimed to quantify the association between filtered, boiled, and total coffee consumption and the risk of bladder, esophageal, kidney, pancreatic, and stomach cancers. We used data from the Norwegian Women and Cancer Study and the Northern Sweden Health and Disease Study. Information on coffee consumption was available for 193,439 participants. We used multivariable Cox proportional hazards models to calculate hazard ratios (HR) with 95% confidence intervals (CI) for the investigated cancer sites by category of total, filtered, and boiled coffee consumption. Heavy filtered coffee consumers (≥ 4 cups/day) had a multivariable adjusted HR of 0.74 of being diagnosed with pancreatic cancer (95% CI 0.57–0.95) when compared with light filtered coffee consumers (≤ 1 cup/day). We did not observe significant associations between total or boiled coffee consumption and any of the investigated cancer sites, neither in the entire study sample nor in analyses stratified by sex. We found an increased risk of bladder cancer among never smokers who were heavy filtered or total coffee consumers, and an increased risk of stomach cancer in never smokers who were heavy boiled coffee consumers. Our data suggest that increased filtered coffee consumption might reduce the risk of pancreatic cancer. We did not find evidence of an association between coffee consumption and the risk of esophageal or kidney cancer. The increased risk of bladder and stomach cancer was confined to never smokers.en_US
dc.description.sponsorshipUiT The Arctic University of Norwayen_US
dc.descriptionAccepted manuscript version. Published version available at <a href=https://doi.org/10.1007/s10654-018-0369-9> https://doi.org/10.1007/s10654-018-0369-9</a>.en_US
dc.identifier.citationLukic, M., Nilsson, L.M., Skeie, G., Lindahl, B. & Braaten, T. (2018). Coffee consumption and risk of rare cancers in Scandinavian countries. <i>European Journal of Epidemiology</i>. https://doi.org/10.1007/s10654-018-0369-en_US
dc.identifier.cristinIDFRIDAID 1622374
dc.identifier.doi10.1007/s10654-018-0369-9
dc.identifier.issn0393-2990
dc.identifier.issn1573-7284
dc.identifier.urihttps://hdl.handle.net/10037/14635
dc.language.isoengen_US
dc.publisherSpringeren_US
dc.relation.journalEuropean Journal of Epidemiology
dc.rights.accessRightsopenAccessen_US
dc.subjectVDP::Medical disciplines: 700::Health sciences: 800en_US
dc.subjectVDP::Medisinske Fag: 700::Helsefag: 800en_US
dc.subjectVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Oncology: 762en_US
dc.subjectVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Onkologi: 762en_US
dc.subjectCoffeeen_US
dc.subjectFiltereden_US
dc.subjectBoileden_US
dc.subjectCanceren_US
dc.subjectBladderen_US
dc.subjectEsophagealen_US
dc.subjectKidneyen_US
dc.subjectPancreaticen_US
dc.subjectStomachen_US
dc.subjectProspective cohort studyen_US
dc.titleCoffee consumption and risk of rare cancers in Scandinavian countriesen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel